Arcturus Therapeutics, Inc. recently presented encouraging non-human primate studies concerning its preclinical messenger RNA therapies for the potential treatment of…
Articles by Maureen Newman
New ways of treating cystic fibrosis are under development at the University of Dundee. Along with colleagues in Italy, France,…
OrPro Therapeutics, Inc. is presenting the newest data concerning its leading pre-clinical therapeutic, ORP-100, at the 28th Annual North…
Young adults and children with cystic fibrosis in the United States have better lung function than those who live…
Any concern that may exist over cystic fibrosis patients receiving nasal live-attenuated influenza vaccine (LAIV) due to infection risk…
Drug development companies such as NovaBiotics that are devoted to designing and developing treatments for…
Cystic fibrosis is among the numerous chronic conditions categorized as rare diseases. As many cystic fibrosis patients know, a…
Vertex Pharmaceuticals will be presenting 15 abstracts at the 28th Annual North American Cystic Fibrosis Conference (NACFC) held…
Sildenafil, antioxidants, and gene therapy for cystic fibrosis treatment are part of an arsenal of studies in progress at…
In light of the news that…